![]() WNY1613 structure
|
Common Name | WNY1613 | ||
---|---|---|---|---|
CAS Number | 2650546-39-5 | Molecular Weight | 557.65 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C29H35N9O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of WNY1613WNY1613 is a potent and selective PI3Kδ inhibitor with piperazinone-containing purine scaffold. WNY1613 induces cancer cell apoptosis and inhibits the phosphorylation of PI3K downstream components in NHL cell lines. WNY1613 exhibits anti-NHL activity in vitro and in vivo[1]. |
Name | WNY1613 |
---|
Description | WNY1613 is a potent and selective PI3Kδ inhibitor with piperazinone-containing purine scaffold. WNY1613 induces cancer cell apoptosis and inhibits the phosphorylation of PI3K downstream components in NHL cell lines. WNY1613 exhibits anti-NHL activity in vitro and in vivo[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C29H35N9O3 |
---|---|
Molecular Weight | 557.65 |